Ionis Pharmaceuticals Inc. Common Stock vs Trane Technologies plc — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B), while Trane Technologies plc trades at $471.29 (market cap $105.17B). The key difference: Trane Technologies plc is far larger — about 14.9× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Trane Technologies plc pays a 0.88% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals.
| IONS | TT | |
|---|---|---|
Market Cap | $7.04B | $105.17B |
Volume | 2,977,440 | 1,040,183 |
Sector | Health | Industrials |
52-Week High | $86.50 | $503.46 |
52-Week Low | $42.38 | $376.43 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $6.60B | $108.47B |
Dividend Yield | — | 0.88% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →Trane Technologies plc is a global climate solutions company that designs, manufactures, and services heating, ventilation, and air conditioning (HVAC) and transport refrigeration equipment under its Trane and Thermo King brands.
Read more on TT →